cro quality benchmarking – phase iv service providers (2014)

9
QUALITY CRO BENCHMARKING P H A S E I V CRO Quality Benchmarking – Phase IV Service Providers (2014) [email protected] ©2014 Industry Standard Research www.ISRreports.com PREVIEW

Upload: industry-standard-research

Post on 22-Apr-2015

148 views

Category:

Health & Medicine


0 download

DESCRIPTION

In its 6th year, ISR’s “CRO Quality Benchmarking – Phase IV Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied satisfaction ratings from 224 service encounters across 24 Phase IV CROs, making this report the most comprehensive assessment of Phase IV CRO service quality in the industry. See more: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iv-service-providers-2014/

TRANSCRIPT

Page 1: CRO Quality Benchmarking – Phase IV Service Providers (2014)

QUALITYCRO

BENCHMARKING

PHASE IV

CRO Quality Benchmarking – Phase IV Service Providers (2014)

[email protected]

©2014 Industry Standard Research www.ISRreports.com

PREVIEW

Page 2: CRO Quality Benchmarking – Phase IV Service Providers (2014)

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 2

act with confidence

Report Overview

In its 6th year, ISR’s “CRO Quality Benchmarking – Phase IV Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied satisfaction ratings from 224 service encounters across 24 Phase IV CROs, making this report the most comprehensive assessment of Phase IV CRO service quality in the industry.

228Charts and Graphs

103Respondents

136Pages

224Service Encounters 1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions

• Phase IV Leaders• Proposal Volume• Service Provider Usage• Service Provider Preference• Service Provider Cost Perceptions

2. Service Provider Selection Drivers• Most Important Service Provider Attributes• Service Provider Attributes Gaining Importance

3. Service Provider Performance and Scorecards Across Attributes• Staff Characteristics Ratings• Operational Excellence Ratings• Organizational and Finance Ratings• Performance Summary by Category• Service Provider Loyalty

4. Service Provider Service Quality Profiles

5. All Study Data

How you can use this report:Study Sponsors• Make a more informed purchase of Phase

IV services by understanding which service providers best fit your company’s needs

• Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 25 critical attributes

• Pinpoint potential delivery concerns early in a CRO relationship/ evaluation in order to develop proactive strategies to address potential gaps

Phase IV Service Providers• Uncover your own — and competitor —

delivery strengths and weaknesses• Design messaging to tout your company’s

strengths• Compete more effectively by understanding

buyers’ selection criteria and outsourcing trends

NEXT: Companies Included

Report Structure:

Page 3: CRO Quality Benchmarking – Phase IV Service Providers (2014)

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 3

act with confidence

Service Quality Metrics• Commercial market

knowledge

• CRA quality

• Project manager quality

• Project team chemistry

• Responsiveness

• Staff turnover

• Therapeutic expertise

• Timely project communications

• Data quality

• Local market / Regulatory knowledge

• Meeting database lock timelines

• Meeting first patient / first visit timelines

• Meeting overall project timelines

• Network of sites / investigators

• Offered innovative solutions

• Patient recruitment strategy

• Speed of site / investigator recruitment

• Speed of site start-up

• Technology for real-time access to data

• Up-front contingency planning, risk management

• Breadth of services

• Financial strength / stability

• Global footprint

• Low cost

• Minimizing change orders

CROs Included in this Report• Accenture• Bioclinica• Biomedical Systems• Chiltern• Clinipace• Cognizant• Covance• DCRI - Duke

• Eurofins• ICON• INC Research• inVentiv Health Clinical• Mapi• PAREXEL• PPD• PRA

• Premier Research• Quintiles• Radiant• SGS Life Sciences• Tata• Theorem• UBC• Worldwide Clinical Trials

6% C-level

8% President/ VP

52% Director

31% Manager

3% Other

Participant Job Title Participant Geography Participant Company Size

67% Large Companies (R&D $1B or more)

24% Mid-Size Companies (R&D $100M-$999M)

9% Small Companies (R&D less than $100M)

53% North America

12% Asia / Other

35% Europe

Report Metrics

Respondent Demographics (N=103)

Participant Experience: Mean = 14.7 years

Page 4: CRO Quality Benchmarking – Phase IV Service Providers (2014)

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 4

act with confidence

Table of Contents

For full table of contents and additional sample pages, download the full pre-view, free on our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iv-service-providers-2014/

Page 5: CRO Quality Benchmarking – Phase IV Service Providers (2014)

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 5

act with confidence

act with confidence

Introduction

www.ISRreports.com ©2014 | CRO Quality Benchmarking — Phase IV Service Providers (2014) 6

Introduction

Welcome to ISR’s 2014 CRO Quality Benchmarking - Phase IV Service Providers report� This report marks the sixth edition of this study and, though the study design is revisited and refreshed each year to account for evolution within the industry, the impetus for performing this research remains the same� Over time, Industry Standard Research has accumulated a wealth of knowledge around service quality and CRO performance� Understanding and utilizing this information allows stakeholders within the industry to make informed decisions when choosing a CRO for Phase IV services�

ISR knows that selecting a CRO isn’t easy� There is a myriad of factors to evaluate for each CRO being considered� Does the provider have the necessary therapeutic expertise? Will the trial be completed on time and within budget? Does the provider have sufficient knowledge about local markets and regulatory environments? Without prior experience with a provider, purchasers of CRO services are often forced to rely on incomplete or biased assessments of CRO performance passed on through word of mouth from peers within the industry�

In the CRO Quality Benchmarking - Phase IV report, ISR provides the data necessary to answer these questions – and many more – with confidence� 103 decision-makers have weighed in with their CRO selection criteria and outsourcing behaviors� They have provided feedback on 224 recent service encounters across 24 Phase IV CROs� Nine providers have received detailed profiles�

Not only does this report enable more educated purchases of CRO services, it also allows Phase IV service providers to get a behind-the-scenes look at customers’ perceptions of their performance� Providers can determine areas of strength and understand where they may need to close the gap relative to competitors� As they say, knowledge is power� Having a grasp on customer beliefs, attitudes, and experiences will help CROs effectively promote their strengths and improve areas in which they are falling short�

Sample Page

Page 6: CRO Quality Benchmarking – Phase IV Service Providers (2014)

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 6

act with confidence

act with confidence

Service Provider Performance and Scorecards Across Attributes

www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase I Service Providers (2014) 27

Figure 2 – “Operational Excellence” Ratings

Performance in Operational Excellence shows more variability among Phase I providers� The non-large, multi-service providers Quotient Clinical and SGS Life Sciences stand out for going beyond expectations as well as Phase I focused provider Clinical Research Services (CRS)� Respondents also rate PPD as more frequently exceeding expectations in Operational Excellence compared to other large, multi-service providers�

Technology for real-time

access to data

Speed of site

start-upData

Quality

Local market /

regulatory knowledge

Meeting Overall Project

Timelines

Meeting Database

Lock Timelines

Meeting First Patient / First Visit Timelines

O�ers Innovative Solutions

Patient / Volunteer

Recruitment

Up-front contingency planning, risk management

Timely project communications

Covance

ICON

INC Research

inVentiv Health Clinical

PAREXEL

PPD

PRA

Quintiles

Charles River

Medpace

Premier Research

Quotient Clinical

SGS Life Sciences

US Oncology

Celerion

Clinical Research Services (CRS)

WCCT Global

Operational Excellence

LARGE MULTI-SERVICE CROS

NON-LARGE MULTI-SERVICE CROS

PRIMARILY PHASE I FOCUSED CROS

Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency

© Industry Standard Research

Sample Page

Figure 1 – Staff Characteristics Ratings

Company A

Company B

Company C

Company D

Company E

Company F

Company G

Company H

Company I

Staff turnover

CRA quality

Project team

chemistry

Project manager quality Responsiveness

Therapeutic expertise

Timely project communications

Commercial market

knowledge

Sta Characteristics

Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency

Page 7: CRO Quality Benchmarking – Phase IV Service Providers (2014)

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 7

act with confidence

Sample PageSample Page

For full table of contents and additional sample pages, download the full pre-view, free on our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iv-service-providers-2014/

Page 8: CRO Quality Benchmarking – Phase IV Service Providers (2014)

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 8

act with confidence

Ordering Information

Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.   For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at www.ISRreports.com, email [email protected], or follow us on twitter @ISRreports.

About Industry Standard Research

Save on this, or any ISR report, by

registering a free account

Register now• Receive a $250 instant credit towards any ISR report• Earn 10% credit towards all future purchases• Receive advanced notifications on ISR’s latest reports and free resources

For pricing and ordering information, visit our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iv-service-providers-2014/

Page 9: CRO Quality Benchmarking – Phase IV Service Providers (2014)

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase IV Service Providers (2014) 9

act with confidence

www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 9

act with confidence

www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10

act with confidence

www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10

act with confidence

The ISR DifferenceCustom-quality syndicated market research

www.ISRreports.com

ISR's Reports The Common Syndicated Reportvs.

How confident are you?

vs.Data Collection

ISR's proprietary data collection tools and channels support fast,

high quality data collection

Struggle to recruit the right targets and enough of them

vs.Sample Sizes

Robust sample sizes that instill confidence

Often insufficient industry representation that leaves you

defending results

vs.vs.Research methods

Mostly primary research;

always appropriate for the topic

One size fits all; usually publically

available data

vs.vs.Respondents

Sophisticated screening ensures genuine decision-makers

Undisclosed methodologies and

respondent demographics

vs.vs.Analysts

Decades of experience means more insights that are

immediately usable

Junior analysts capable of reporting numbers